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Abstract. Age-related macular degeneration (AMD) is the leading cause of irreversible vision 
loss in people aged 50 and older in the developed world. Early detection and treatment of AMD 
play the key role in helping patients at high risk for developing exudative to maintain their vision 
or slow down the progression of the disease. In this paper, the new technique for AMD evaluation 
using ultrasound spectral analysis is presented. Our aim was to compare B scan ultrasound signals 
backscattered from healthy tissues of macular area with signals from nonexudative and exudative 
AMD areas. In case-control study of 64 patients (144 tissues) we compared 82 cases of healthy 
tissue of macular area (I group) with 35 cases of nonexudative AMD (II group) and 30 cases of 
exudative AMD (III group) using B scan ultrasound. Estimated results showed that B scan 
amplitude and spectral intercept are informative to distinguish healthy tissues of macular area 
from AMD and spectral slope spectral, momentary bandwidth allow us to distinguish forms of 
AMD (nonexudative and exudative).We suggest that ultrasound spectral analysis is noninvasive, 
widely available, easy-to-use and less expensive method which can be used as an additional 
diagnostic tool in AMD detecting and differentiating when there are no possibilities to use more 
specific examination. 
Keywords: ultrasound, age-related macular degeneration, spectral analysis, radiofrequency 
signals. 
1. Introduction 
Age-related macular degeneration (AMD) is a degenerative disorder of the central retina and 
represents the leading cause of severe visual impairment in the elderly population of industrialized 
societies [1]. Epidemiological studies estimate that the prevalence of AMD in Australia, Europe 
and North America is 0.2 % in 55-64 year old patients and it increases to 13 % in the age group 
of 85 years [2]. The disease is more common in Caucasian individuals than in pigmented  
races [3]. 
AMD typically presents with distortion of straight lines or edges, rapid onset of visual loss, 
and/or a blind spot in central or paracentral visual field [4]. A main cause of severe vision loss due 
to the disease is the development of choroidal neovascularization (CNV), leading to the exudative 
form of AMD It is therefore crucial that development of a new CNV be detected as early as 
possible, preferably before the development of a full-blown lesion which has already led to loss 
of letters, lines, and quality of life [5]. 
Treatment of exudative AMD may involve the use of anti-VEGF therapy, thermal laser 
treatment or photodynamic therapy. In patients presenting with CNV, treatment with intravitreal 
injections of anti-vascular endothelial growth factor (VEGF) agents may improve visual acuity 
(VA) by three lines or more in 30-40 % of patients and may prevent deterioration of visual  
acuity [6]. However, treatment of exudative AMD generally reduces but does not eliminate the 
risk of severe vision loss. 
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Evaluation, detection and treatment of AMD play the key role in helping patients at high risk 
for developing exudative AMD to maintain their vision or slow down the progression of the 
disease. There are tests that are widely used in diagnosis as initial tests for AMD Table 1 and other 
imaging modalities can subsequently be used for further analysis Table 2 [7]. 
Table 1. Initial tests for primary diagnosis of AMD 
Tests Description 
Visual acuity 
(VA) 
One of the first signs or symptoms of visual loss in the early, non-neovascular stages 
of AMD, may be a reduction in reading rate, and near VA is a good predictor of 
reading rate [8]. As AMD progresses both near VA and reading rate reduce. It is 
thought that if near VA is a great deal worse than distance VA, a scotoma is 
impending near vision [9]. This method, while having the advantage of being easily 
accessible, has not been proven in the literature [5]. 
Amsler grid 
test 
It can be used daily as per instructions to test for symptoms of macular degeneration 
which can include one or more signs like distortion where straight lines appear wavy 
or bent, dark patches or empty spaces appearing in the centre of vision [10]. 
However, it was found that the sensitivity of the test ranged from 0.34 to 1.0 and its 
specificity ranged from 0.85 to 1.0 [11]. 
Color fundus 
photography 
Gold standard for AMD screening and is a rapid way to look for soft drusen, the 
earliest sign of AMD [12]. A digital fundus camera is used to capture an image of the 
interior of the eye, including the retina, optic disc, and macula [7]. 
Color contrast 
sensitivity test 
Testing basic aspects of vision such as contrast sensitivity is more likely to reflect an 
alteration of retinal function in early AMD [13]. Although acuity testing is simple to 
implement in a clinical setting, it does not give exclusive information on retinal 
function in early AMD when changes in VA are minimal  
(two letter loss, or logMAR 0.04) [14]. 
Table 2. Tests for further and more specific analysis of AMD 
Tests  Description 
Fundus 
Autofluorescence 
(FAF) Imaging 
It is an in vivo imaging method for metabolic mapping of naturally or 
pathologically occurring fluorophores of the ocular fundus [7]. FAF imaging may 
be used to screen early AMD [15]. 
Optical Coherence 
Tomography (OCT) 
OCT functions as a type of optical biopsy, providing information on retinal 
pathology in real time, with a resolution vastly better than magnetic resonance 
imaging (MRI) or ultrasound. A major strength of SD-OCT over other imaging 
modalities is its ability to capture 3D-volumetric information about the pathologies 
[7]. 
Optical Coherence 
Tomography 
Angiography 
(OCTA) 
OCT angiography (OCTA) is an advanced imaging modality that employs 
amplitude or phase decorrelation technology with high-frequency and dense 
volumetric scanning to detect erythrocyte movement, allowing direct visualization 
of blood vessels in vivo, without the use of exogenous dyes [16, 17]. 
Angiography 
Fluorescein (FA) 
and 
Indocyanine Green 
(ICG) 
Angiography, both fluorescein and indocyanine green (ICG), is useful test to look 
for choroidal neovascularization. A small gage needle attached to a plastic catheter 
is inserted into a vein, usually in the arm, and a fluorescent dye is injected through 
the catheter and enters the bloodstream. As the dye enters the blood vessels of the 
eye, a series of pictures are taken of the retina using a fundus camera. Special filters 
matched for the excitation and emission wavelengths of the dye are placed in a 
beam splitter so that only the fluorescence of the dye in the blood vessels is 
visualized against the dark remainder of the background retinal tissue [7]. 
However, sometimes there are no possibilities to use these diagnostic tools. In some cases, 
ophthalmoscopy, fundus photography, OCT and other diagnostic methods are impossible due to 
opacification of light transmitting media or other reasons like walking disability after stroke, 
cardiovascular, neurological and oncological diseases, also multiple organ failures. 
Because overlying opacities have no effect on the examining ultrasonographic frequencies, 
ultrasound has the unique ability to depict the nature of intraocular pathology when the media are 
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optically opaque [18]. 
Ultrasonic methods stand out in ophthalmology with good informative value among the 
noninvasive methods. Early detection of lesions and accurate diagnosis leads to effective 
assistance [19]. During the past two decades, improvements in the resolution and reliability of 
instrumentation and techniques have allowed A-scan and B-scan ultrasonography to join direct 
visualization, fluorescein angiography, and radioactive phosphorus testing as primary diagnostic 
modalities in the evaluation of eye [18]. 
In the last decade, ultrasound probes with higher frequency and higher resolution have been 
commercialized, such as the 20 MHz probe used for eye posterior pole studies. Frequency is 
important in ultrasound because it is directly related to resolution and inversely related to 
penetration of ultrasonographic images [20]. 
In this study, we were investigating a noninvasive ultrasound imaging method which is widely 
available not only in tertiary-level hospitals, easy-to-use and less expensive than other imaging 
methods in order to detect AMD as early as possible and achieve better outcome in treatment. Our 
aim was to compare B scan ultrasound signals backscattered from healthy tissues of macular area 
with signals from nonexudative and exudative AMD areas. 
2. Methods and data 
Patients, who came to Hospital of Lithuanian University of Health Sciences Kaunas Clinics 
Eye Clinic from February 1st, 2016 to August 31st, 2016 were included in the study. We 
performed case-control study of 64 patients (144 tissues). We examined 82 cases with healthy 
tissue of macular area as a control group, 32 cases with nonexudative AMD and 30 cases with 
exudative AMD. We excluded eyes with glaucoma, diabetic maculopathy, high degree myopia, 
inflammatory retinal and choroidal diseases. 
Distribution of patients by sex in 144 cases of examined tissues was 92 women and 52 men in 
total. Average age was 72.82±8.83 years. All participants were above 50 years old. The youngest 
patient was 50 years old and the oldest – 90 years old.  
Before echography using B mode Mentor™ Advent ultrasonic diagnostic imaging system all 
patients underwent comprehensive ophthalmological examination. Color fundus photography, 
optical coherence tomography imaging was used to evaluate AMD and differentiate healthy eyes, 
exudative and nonexudative AMD eyes (Fig. 1). Best-corrected visual acuity (measured in 
decimals from 0.1 to 1.0) was evaluated using Landolt’sings (C optotypes) by Snellen test types 
at a 5 meter distance from the chart. 
 
Fig. 1. Color fundus photographs of the human retina performed with OPHTEK Visucam (top) and 
High-quality spectral-domain optical coherence tomography (SDOCT) images of the macula (bottom):  
a) healthy eye, b) nonexudative AMD, c) exudative AMD 
The hardware and software system used for acquisition of ultrasound B scan raw signals is 
described by Jurkonis and others [21]. 
The ultrasound B scan system is Mentor (Advent, Norwell, MA), with mechanical scanning 
transducer of 12 MHz, which is an original system supplemented with signal acquisition system 
[22]. System assures acquisition of raw ultrasound diagnostic signals with 250 MHz sampling 
frequency and 8 bits amplitude resolution. B scan raw signals were stored into database on 
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computer hard disc and analyzed off-line. Analysis was performed by ophthalmologist using 
NICDIT v1.2 software. B scan raw signals were loaded into software and reviewed [23]. Two 
areas were investigated: healthy tissue area of macular zone and area of AMD zone. Both regions 
were of the same length 1.5 mm in all analyzed cases. Regions of interest were selected manually 
by two of the authors RM and IS Fig. 2. If there was not complete agreement between researchers 
these cases were excluded.  
We analyzed radiofrequency row signals using the following five parameters: B scan 
amplitude ܸ , spectral intercept dB, average instantaneous bandwidth MHz, spectral slope 
dB/MHz and spectral momentary bandwidth MHz of approximated backscattered spectra. The 
amplitude of a radio frequency echo signal distribution equals to the sum of the signals from each 
reflecting point in the radiation line. Power spectrum of the echo signal is calculated using the 
discrete Fourier transformation [23]. NICDIT v1.2 software algorithms were used to analyze the 
raw radio frequency signals from selected regions [24]. 
Statistical analysis was performed using the computer program SPSS/W 19.0 (Social sciences 
statistical package program for Windows, Inc., Chicago, Illinois, USA). T test and the  
Mann-Whitney U test were used for the comparison of all groups. A statistically significant 
difference was considered if ݌ < 0.05 and the confidence interval was set as 95 %. 
 
Fig. 2. Photographs of the human retina performed with B scan ultrasound:  
a) healthy eye, b) nonexudative AMD, c) exudative AMD  
3. Results 
Preliminary conclusions can be made after study of 82 cases with healthy tissue area compared 
to 32 cases with nonexudative AMD and 30 cases with exudative AMD. Characteristics of 
separate groups are shown in Table 3. 
Table 3. The characteristics of patients with AMD and healthy subjects included to the study 
Characteristic Results Healthy tissues of macular area Nonexudative AMD Exudative AMD 
Men, ݊ (%) 30 (36.59) 13 (40.63) 9 (30) 
Women, ݊ (%) 52 (63.41) 19 (59.37) 21 (70) 
Age, min-max (mean±SD) 50-90 (71.39±9.26) 56-87 (75.34±7.44) 62-84 (76.73±6.13) 
3.1. B scan amplitude, V  
The analyses of B scan amplitude showed a significant difference between control group 
compared to nonexudative AMD group and exudative AMD group  
(mean difference –0.022±0.007, ݌ =  0.004; mean difference –0.032±0.007, ݌ <  0.001, 
respectively). We didn’t obtain significant difference of the amplitude comparing nonexudative 
AMD group to exudative AMD group (mean difference 0.01±0.008, ݌ = 0.68). The largest B-scan 
amplitude was observed in exudative AMD group (0.088±0.041 V), the middle B-scan amplitude 
– in nonexudative AMD group (0.078±0.031 V) and the smallest value was found in healthy 
tissues area of control group (0.056±0.029 V) (Fig. 3). 
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3.2. Spectral intercept, dB  
Significant differences in the mean values of mean spectral intercept between control group 
and nonexudative AMD group (mean difference –5.78±1.2, ݌ < 0.001), also between control 
group and exudative AMD (mean difference –3.23±1.22, ݌ = 0.028) were found. However, there 
were no significant difference between nonexudative and exudative AMD group (mean difference 
2.55±1.46, ݌ = 0.246). The highest value of spectral intercept was determined in nonexudative 
group (–4.02±5.55 dB) and the lowest value of spectral intercept was detected in control group  
(–9.8±5.57 dB) (Fig. 4). 
 
Fig. 3. Mean B scan amplitude in different groups 
(*݌ = 0.004; **݌ < 0.001) 
 
Fig. 4. Mean spectral intercept in different groups 
(*݌ < 0.001; **݌ = 0.028) 
3.3. Average instantaneous bandwidth, MHz 
We estimated that average instantaneous bandwidth had similar results in comparing healthy 
tissue area with areas of AMD – mean difference between control and nonexudative AMD group 
was 0.02±0.06, ݌ > 0.05, between control and exudative AMD group –0.08±0.06, ݌ = 0.658. 
Also, no significant difference was estimated between nonexudative and exudative AMD groups 
(mean difference 0.1±0.07, ݌ = 0.568). The highest value of this parameter was established in 
nonexudative AMD group (1.13±0.27 MHz) and the lowest – in exudative AMD group 
(1.04±0.17 MHz). 
3.4. Spectral slope, dB/MHz 
The analyses of mean spectral slope showed statistically significant differences between 
control and nonexudative AMD group (mean difference 0.32±0.11, ݌ =0.012), also between 
nonexudative AMD and exudative AMD group (mean difference 0.36±0.13, ݌ = 0.021). There 
were no significant mean differences between control and exudative AMD group (mean difference 
0.05±0.11, ݌ > 0.05). We determined that the highest spectral slope was in healthy tissues area of 
control group (–2.08±0.5 dB/MHz) and the lowest spectral slope was found in nonexudative AMD 
group (–2.4±0.48 dB/MHz) (Fig. 5). 
3.5. Spectral momentary bandwidth, MHz 
We estimated that results of comparing spectral momentary bandwidth between control and 
nonexudative AMD groups, also between nonexudative and exudative AMD groups were 
statistically significant (mean difference 0.36±0.15, ݌ =  0.008; mean difference 0.45±0.19,  
݌ = 0.045, respectively). We did not find significant difference between control and exudative 
group (mean difference 0.09±0.16, ݌ =  0.295). The highest value of spectral momentary 
bandwidth was detected in patiens with exudative AMD (10.29±0.73) and the lowest value was 
detected in patiens with nonexudative AMD (9.84±0.65) (Fig. 6). 
Summary of results characterizing parameters extracted from radio frequency of ultrasound 
2629. ULTRASOUND SPECTRAL ANALYSIS-BASED ASSESSMENT OF MACULAR AREAS IN PATIENTS WITH AGE RELATED MACULAR DEGENERATION.  
BRIGITA BŪDIENĖ, IEVA SAKALAUSKAITĖ, RASA MIKALAUSKAITĖ, DAIVA STANISLOVAITIENĖ, JURGIS TRUMPAITIS, DALIA ŽALIŪNIENĖ 
4690 © JVE INTERNATIONAL LTD. JOURNAL OF VIBROENGINEERING. SEP 2017, VOL. 19, ISSUE 6. ISSN 1392-8716  
signals, defined as mean and standard deviation, are presented in Table 4. 
 
Fig. 5. Mean spectral slope in different groups  
(*݌ = 0.012; **݌ = 0.021) 
 
Fig. 6. Mean spectral momentary bandwidth in 
different groups (*݌ = 0.008; **݌ = 0.045) 
Table 4. Differentiation parameters (mean, std. deviation)  
of B scan ultrasound signals backscattered from intraocular tissues 
Parameter 
Area in tissues 
Healthy tissues  
of macular area 
Nonexudative  
AMD 
Exudative  
AMD 
B scan amplitude, ܸ 0.06±0.03 0.08±0.03 0.09±0.04 
Spectral intercept, dB –9.8±5.57 –4.02±5.55 –6.5±6.34 
Average instantaneous bandwidth, MHz 1.11±0.33 1.13±0.27 1.04±0.17 
Spectral slope, dB/MHz –2.08±0.5 –2.4±0.48 –2.04±0.6 
Spectral momentary Bandwidth, MHz 10.2±0.76 9.84±0.65 10.29±0.73 
4. Discussion 
Ultrasound B scan has proven to be a precise and valid alternative aiding in the prompt and 
early diagnosis in cases of ocular trauma where opacification of the light conducting media has 
occurred. This is especially important in a setting where the overall burden of trauma on healthcare 
in general and on emergency department in particular is increasing every year [25]. 
Trumpaitis et al. study has shown that the lower amplitude, lower spectral intercept, high 
spectral slope and high momentary bandwidth are typical for choroidal melanoma if compared 
with hemangioma or healthy tissues. This allows us to distinguish healthy tissues from the 
abnormal tumor tissues and also to identify and differentiate choroidal melanoma from 
hemangioma [23]. 
Trumpaitis et al. obtained results in their study that showed there was statistically significant 
difference between the radio frequent ultrasound signal parameters (amplitude, spectrum slope, 
spectrum intercept and momentary bandwidth) in the healthy tissue area and in the area with the 
intraocular tumor – melanoma before and after treatment. According to this research, tested 
parameters allows us to distinguish healthy tissues from the abnormal tumor tissues and also to 
identify choroidal melanoma [24]. 
Ultrasound imaging USI allows measurement of blood flow velocities BFVs in the retrobulbar 
arteries [26]. In patients with AMD, USI thus allows for the characterization of BFV changes in 
all retrobulbar arteries after a single intravitreal injection of bevacizumab [28]. In Bonin, et al. 
study ultrasound imaging was performed using a Sonoline Elegra Advanced System (Siemens AG, 
Erlangen, Germany) equipped with a linear transducer type 7.5 L40 9 MHz. The researchers 
highlighted an unexpected effect of intravitreal ranibizumab on retrobulbar arteries in patients 
with exudative AMD, consisting of reduced blood flow velocity in the posterior ciliary, central 
retinal and ophthalmic arteries, suggesting that anti-angiogenic therapy could impair the native 
choroidal and retinal vascular circulations [27]. 
To the best of our knowledge, this is the first study trying to figure out B-scan spectral analysis 
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possibilities for detecting age related macular degeneration. Our study has shown that amplitude, 
spectral intercept, spectral slope and momentary bandwidth are different in AMD tissues if 
compared with healthy tissues. This allows us to distinguish healthy tissues from AMD affected 
tissues and also to identify this retinal disease. 
B. Budiene – participants data examination, manuscript preparation (drafted manuscript). D. 
Stanislovaitiene – participants’ data examination, helped to draft manuscript. I. Sakalauskaite – 
participant’s data analysis, statistical analysis (has made analysis and interpretation of data). R. 
Mikalauskaite – participant’s data analysis, statistical analysis (has made analysis and 
interpretation of data). J. Trumpaitis – ultrasound examination and data interpretation. D. 
Zaliuniene – has made substantial contributions to conception and design, revised manuscript 
critically. All authors read and approved the final manuscript. 
5. Conclusions 
The timeframe from appearance of symptoms to diagnosis and treatment AMD is not ideal. 
Accordingly, several methods have been proposed for early detection of CNV, which may be 
unnecessarily delayed [6]. In the present study, we were investigating clinical uses of ultrasound 
imaging and spectral analysis in order to detect AMD and start effective treatment as early as 
possible. Estimated results showed a statistically significant difference between the radio 
frequency ultrasound signal parameters in comparison of healthy tissues area with tissues affected 
with nonexudative and exudative AMD. 
Analyzing values of B scan amplitude, spectral intercept, spectral slope and spectral 
momentary bandwidth we revealed a significant difference between healthy tissues comparing to 
nonexudative AMD tissues (݌ = 0.004, ݌ < 0.001, ݌ = 0.012 and ݌ = 0.008, respectively). B 
scan amplitude and spectral intercept showed significant differences between control group and 
exudative AMD group (݌ < 0.001, ݌ = 0.028, respectively).  
Two of the parameters – spectral slope and spectral momentary bandwidth were the ones to 
show a significant difference between nonexudative and exudative AMD (݌ = 0,021, ݌ = 0.045, 
respectively). 
To summarize B scan amplitude and spectral intercept are informative to distinguish healthy 
tissues of macular area from AMD (nonexudative and exudative). Spectral slope and spectral 
momentary bandwidth allow us to distinguish forms of AMD. Spectral analysis can be used as an 
additional diagnostic tool for AMD and for differentiating nonexudative from exudative AMD. 
We suggest that this non-invasive ultrasound expert system provides the new opportunities in 
ophthalmology, allowing us to detect and differentiate AMD when other diagnostic methods are 
unavailable or we cannot use them due to complicated patient condition (for ex., opacification of 
light transmitting media, disability after stroke and other cardiovascular diseases that cause 
disability to move). Further investigation including more patients should be done in order to 
evaluate the options of spectral analysis. 
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